CCB
Coastal Financial Corporation
CCB offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
JPM
JPMorgan Chase & Co.
JPM has the edge over CCB overall, supported by lower modeled downside and stronger fundamentals.
CCB Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| N/A | |
| N/A |
CCB's revenue is currently healthy, but its profitability is under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like CCB.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
CCB PE Valuation
CCB has no meaningful PE right now: it lost money over the past year.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
CCB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for CCB, with profitability improving.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
CCB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.69 | — |
| Q3 2026 | -$0.25 | -108% |
| Q2 2026 | -$0.26 | -108% |
| Q1 2026 | $3.21 | -5.3% |
| Q4 2025 | $3.06 | -6.1% |
| Q3 2025 | $3.17 | +6.7% |
| Q2 2025 | $3.26 | +19% |
| Q1 2025 | $3.39 | +19% |
| Q4 2024 | $3.26 | -0.3% |
CCB has swung to a loss: it lost $0.25 per share over the past year, after a profit the year before.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over CCB on earnings quality, reporting a profit while its opponent remains loss making.
CCB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $149.3M | +3.2% |
| Q2 2026 | $178.1M | +49% |
| Q1 2026 | $149.4M | +7.1% |
| Q4 2025 | $138M | -5.8% |
| Q3 2025 | $144.7M | -5% |
| Q2 2025 | $119.4M | -12% |
| Q1 2025 | $139.5M | -5.6% |
| Q4 2024 | $146.5M | +18% |
CCB's revenue is growing: $149M last quarter, up 3.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 12% | 0 points |
| Q2 2026 | -31% | -43 points |
| Q1 2026 | 9.8% | +1.3 points |
| Q4 2025 | 12% | +0.7 points |
| Q3 2025 | 12% | +1.6 points |
| Q2 2025 | 12% | +1 points |
| Q1 2025 | 8.4% | +2.5 points |
| Q4 2024 | 12% | +2.2 points |
CCB's operating margin was 12% last quarter, about level with the same quarter a year ago.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM has the edge over CCB on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over CCB on profitability, with a higher operating margin.
CCB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $39.6M | -31% |
| Q2 2026 | $74.6M | +17% |
| Q1 2026 | $74.1M | +7.6% |
| Q4 2025 | $55.9M | -14% |
| Q3 2025 | $57.4M | -5.8% |
| Q2 2025 | $64M | -8.5% |
| Q1 2025 | $68.9M | +15% |
| Q4 2024 | $65.3M | +36% |
CCB has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
CCB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.1% | +174K shares |
| 1 year | -0.2% | -26.8K shares |
| 3 years | +13% | +1.7M shares |
| 5 years | +24% | +3M shares |
| Available history | +26% | +3.2M shares |
CCB has 15M diluted shares, about the same as a year ago.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over CCB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
CCB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.6x | High |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.9x | Very low |
| Q3 2025 | 0.9x | Very low |
| Q2 2025 | 1.0x | Very low |
| Q1 2025 | 0.7x | Very low |
| Q4 2024 | 0.9x | Very low |
CCB's net debt is about 7.8 years of its operating earnings (EBITDA), up from less than a year a year ago. Net leverage isn't a meaningful measure for financial services companies like CCB.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM has the edge over CCB on leverage, with a lower net debt burden relative to earnings.
CCB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.3 | Neutral |
| Stochastic | 35.0 | Neutral |
CCB's weekly RSI is 35 (neutral) and its Stochastic is 35 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
CCB PE vs Financial Services Sector
| Metric | CCB | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
CCB has no meaningful PE right now: it lost money over the past year.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
CCB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $42.8 | 1.1% above |
| 20 week MA | $51.4 | 16% below |
| 50 week MA | $73.0 | 41% below |
| 100 week MA | $84.0 | 48% below |
| 200 week MA | $64.5 | 33% below |
CCB has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 33% below its 200-week average.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over CCB on trend strength, trading above more of its moving averages.
CCB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.7 | $21.4 | +28% |
| 2021 | $21.4 | $52.0 | +144% |
| 2022 | $52.0 | $47.6 | -8.5% |
| 2023 | $47.6 | $44.4 | -6.7% |
| 2024 | $44.4 | $83.7 | +89% |
| 2025 | $83.7 | $116.9 | +40% |
| 2026 YTD | $116.9 | $43.2 | -63% |
CCB is down 63% so far in 2026, after finishing higher in four of the previous six years.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over CCB on returns for 2026, with the stronger performance.